Nanosonics Ltd Total Assets
Nanosonics Ltd total assets. Based on the latest financial reports, Nanosonics Ltd (NAN) holds total assets worth AU$279.25 Million AUD (≈ $197.59 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Nanosonics Ltd for the company's overall valuation and market capitalisation.
Total Assets of Nanosonics Ltd (2005–2025)
Total assets of Nanosonics Ltd from 2005 to 2025. This chart illustrates how Nanosonics Ltd's total assets have evolved over time, based on quarterly financial data. See Nanosonics Ltd stock quote for real-time trading data and today's change.
Nanosonics Ltd - Asset Composition Analysis
Nanosonics Ltd Total Assets Breakdown (June 2025)
Nanosonics Ltd total assets breakdown as of June 2025. Nanosonics Ltd's total assets of AU$279.25 Million consist of 82.7% current assets and 17.3% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$1.86 Million | 59.2% |
| Accounts Receivable | AU$38.24 Million | 14.0% |
| Inventory | AU$18.63 Million | 6.8% |
| Property, Plant & Equipment | AU$24.38 Million | 9.0% |
| Intangible Assets | AU$1.00K | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2005–2025)
This chart illustrates how Nanosonics Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Nanosonics Ltd's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nanosonics Ltd's current assets represent 82.7% of total assets in 2025, an increase from 0.0% in 2005.
- Cash Position: Cash and equivalents constituted 59.2% of total assets in 2025, down from 67.4% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2005.
- Asset Diversification: The largest asset category is accounts receivable at 14.0% of total assets.
Nanosonics Ltd Competitors by Total Assets
Key competitors of Nanosonics Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Mark Dynamics Indonesia Tbk PT
JK:MARK
|
Indonesia | Rp980.33 Billion |
|
Interojo Inc
KQ:119610
|
Korea | ₩252.22 Billion |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.39 Billion |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
|
Osteopore Ltd
AU:OSX
|
Australia | AU$2.77 Million |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
Nanosonics Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.38 | 5.42 | 8.68 |
| Quick Ratio | 5.75 | 4.94 | 7.83 |
| Cash Ratio | 0.13 | 0.12 | 0.03 |
| Working Capital | AU$196.73 Million | AU$171.33 Million | AU$111.88 Million |
Nanosonics Ltd - Advanced Valuation Insights
This section examines the relationship between Nanosonics Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.56 |
| Latest Market Cap to Assets Ratio | 2.24 |
| Asset Growth Rate (YoY) | 14.8% |
| Total Assets | AU$272.48 Million |
| Market Capitalization | $611.04 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Nanosonics Ltd's assets at a significant premium (2.24x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Nanosonics Ltd's assets grew by 14.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Nanosonics Ltd (2005–2025)
The table below shows the annual total assets of Nanosonics Ltd from 2005 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$272.48 Million ≈ $192.80 Million |
+14.81% |
| 2024-06-30 | AU$237.34 Million ≈ $167.93 Million |
+4.98% |
| 2023-06-30 | AU$226.07 Million ≈ $159.96 Million |
+16.99% |
| 2022-06-30 | AU$193.24 Million ≈ $136.73 Million |
+17.42% |
| 2021-06-30 | AU$164.57 Million ≈ $116.45 Million |
+11.03% |
| 2020-06-30 | AU$148.23 Million ≈ $104.88 Million |
+14.44% |
| 2019-06-30 | AU$129.52 Million ≈ $91.64 Million |
+18.63% |
| 2018-06-30 | AU$109.18 Million ≈ $77.25 Million |
+10.00% |
| 2017-06-30 | AU$99.26 Million ≈ $70.23 Million |
+45.60% |
| 2016-06-30 | AU$68.17 Million ≈ $48.23 Million |
+12.93% |
| 2015-06-30 | AU$60.37 Million ≈ $42.71 Million |
+79.96% |
| 2014-06-30 | AU$33.54 Million ≈ $23.73 Million |
-0.32% |
| 2013-06-30 | AU$33.65 Million ≈ $23.81 Million |
-8.20% |
| 2012-06-30 | AU$36.66 Million ≈ $25.94 Million |
+117.59% |
| 2011-06-30 | AU$16.85 Million ≈ $11.92 Million |
-32.47% |
| 2010-06-30 | AU$24.95 Million ≈ $17.65 Million |
+41.90% |
| 2009-06-30 | AU$17.58 Million ≈ $12.44 Million |
-31.41% |
| 2008-06-30 | AU$25.63 Million ≈ $18.14 Million |
-23.25% |
| 2007-06-30 | AU$33.40 Million ≈ $23.63 Million |
+377.85% |
| 2006-06-30 | AU$6.99 Million ≈ $4.95 Million |
+207.48% |
| 2005-06-30 | AU$2.27 Million ≈ $1.61 Million |
-- |
About Nanosonics Ltd
Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It… Read more